Comprehensive medication guide to Toprol XR including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$30 copay for generic on most commercial and Medicare Part D plans; typically Tier 1–2 with no prior authorization required.
Estimated Cash Pricing
$15–$65 retail for generic depending on dose; as low as $9–$12 with GoodRx or SingleCare coupons for a 30-day supply of the most common doses (50 mg, 100 mg).
Medfinder Findability Score
72/100
Summarize with AI
On this page
Toprol XR is a brand name for metoprolol succinate extended-release, a once-daily prescription tablet used to treat high blood pressure (hypertension), chronic chest pain (angina pectoris), and heart failure with reduced ejection fraction (HFrEF). It belongs to a class of drugs called beta-1 selective (cardioselective) beta blockers and was first approved by the FDA in 1992.
The extended-release formulation delivers metoprolol continuously over 24 hours through a multi-pellet tablet system. This steady delivery avoids the peaks and troughs of immediate-release metoprolol tartrate, providing consistent heart rate and blood pressure control throughout the day and night — including during the high-risk early morning hours.
Generic metoprolol succinate ER is produced by multiple manufacturers and is therapeutically equivalent to the original brand-name Toprol-XL. It is available in four strengths: 25 mg, 50 mg, 100 mg, and 200 mg extended-release tablets.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Toprol XR works by selectively blocking beta-1 adrenergic receptors in the heart. Normally, stress hormones like adrenaline (epinephrine) bind to these receptors to speed up the heart and increase the force of its contractions. By occupying these receptors, metoprolol succinate blocks the "speed up" signal — slowing heart rate, reducing the force of contraction, and lowering blood pressure.
The term "cardioselective" means it preferentially targets beta-1 receptors (found primarily in the heart) over beta-2 receptors (found in the lungs and blood vessels). This selectivity makes it safer for patients with mild asthma or COPD compared to non-selective beta blockers, though caution is still required at higher doses.
In heart failure, this mechanism is counterintuitively beneficial: by reducing the chronic over-stimulation of the heart by catecholamines, long-term beta-blockade allows the heart muscle to recover and remodel, improving ejection fraction and reducing mortality risk. This is why metoprolol succinate is one of only three beta blockers with guideline-directed evidence for survival benefit in HFrEF.
25 mg — extended-release tablet
Starting dose for heart failure (NYHA Class II); also used in hypertension
50 mg — extended-release tablet
Common dose for hypertension and angina
100 mg — extended-release tablet
Most commonly prescribed strength for hypertension and angina
200 mg — extended-release tablet
Higher-dose option for hypertension and angina; maximum studied dose is 400 mg/day
As of 2026, oral metoprolol succinate extended-release tablets are not in an active FDA drug shortage. The medication is manufactured by multiple generic producers and is generally available through major wholesalers. However, patients — particularly those on less common strengths like 25 mg or 200 mg — regularly report stocking gaps at chain pharmacies.
The 50 mg and 100 mg strengths are widely stocked and easy to find. The 25 mg (commonly used in heart failure titration) and 200 mg are less reliably stocked at retail chains. Independent pharmacies typically have better access and can often source any strength within 1-2 business days. Mail-order pharmacies carry broad inventory and are the most reliable option for long-term 90-day supplies.
If you're struggling to find Toprol XR at your usual pharmacy, medfinder calls pharmacies near you to find which ones have your specific dose in stock, and texts you the results. This saves you hours of calling around on your own.
Toprol XR (metoprolol succinate ER) is not a controlled substance, meaning any licensed prescriber can write for it without DEA scheduling restrictions. It is commonly prescribed by a wide range of healthcare providers across specialties.
Cardiologists — for angina, heart failure (HFrEF), post-MI, and arrhythmia rate control
Primary Care Physicians (PCPs) — family medicine and internal medicine for hypertension and follow-up maintenance
Nurse Practitioners (NPs) and Physician Assistants (PAs) — in most states have full prescribing authority for this medication
Electrophysiologists — for rate control in atrial fibrillation and other arrhythmias
Heart failure specialists — for initiation and titration of metoprolol succinate in HFrEF management
Telehealth prescribing is permitted for Toprol XR with no special restrictions. Platforms such as Teladoc, MDLive, and Sesame can evaluate and prescribe this medication for hypertension or as a renewal for existing prescriptions. For heart failure and post-MI management, in-person evaluation with a cardiologist is generally preferred.
No. Toprol XR (metoprolol succinate) is not a controlled substance and is not scheduled by the Drug Enforcement Administration (DEA). It has no known abuse potential or addiction risk. This means there are no special DEA prescribing requirements, no limits on refills set by federal law, and no restrictions on telehealth prescribing.
Patients can receive prescriptions for Toprol XR with multiple refills, and prescriptions can be called in or sent electronically by any licensed prescriber — including via telehealth consultation. Because it is a cardiovascular medication with a serious boxed warning against abrupt discontinuation, it does require a valid prescription, but no controlled substance regulations apply.
The most commonly reported side effects include:
Fatigue and tiredness (most common, often improves after a few weeks)
Dizziness or lightheadedness, especially when standing (orthostatic hypotension)
Slow heart rate (bradycardia) — expected therapeutic effect; concerning if below 50 bpm with symptoms
Cold hands and feet
Headache (usually early in treatment)
Sleep disturbances or vivid dreams
Serious side effects requiring medical attention:
Worsening heart failure (new fluid retention, sudden weight gain, increased breathlessness)
Severe bradycardia or heart block
Bronchospasm (wheezing, difficulty breathing) especially in patients with asthma or COPD
Rebound angina or cardiac events on abrupt discontinuation
Know what you need? Skip the search.
Atenolol
Beta-1 selective, once-daily, inexpensive generic. Approved for hypertension and angina. Not recommended for heart failure. Good alternative for BP and angina patients.
Bisoprolol (Zebeta)
Highest beta-1 selectivity of all beta blockers. FDA-approved for heart failure and hypertension. Preferred in COPD/asthma. Guideline-directed therapy for HFrEF alongside metoprolol succinate.
Carvedilol (Coreg)
Non-selective beta blocker with alpha-1 blockade. Approved for HFrEF and hypertension. Requires twice-daily dosing (or once daily for Coreg CR). Guideline-directed for HFrEF.
Metoprolol Tartrate (Lopressor)
Immediate-release form of the same active ingredient. Requires twice-daily or more frequent dosing. Useful as a short-term bridge when Toprol XR is unavailable. Not FDA-approved for heart failure.
Prefer Toprol XR? We can find it.
Digoxin (Lanoxin)
majorBoth slow AV node conduction; additive bradycardia risk. Monitor heart rate closely.
Verapamil
majorAdditive bradycardia and AV block risk. Combination generally avoided or used with close monitoring.
Diltiazem
majorAdditive bradycardia risk; use with caution.
Clonidine
majorBeta-blocker may worsen rebound hypertension on clonidine withdrawal. Stop beta-blocker before tapering clonidine.
Fluoxetine / Paroxetine
moderateCYP2D6 inhibitors that can double metoprolol blood levels; monitor for excess bradycardia and hypotension.
Diphenhydramine (Benadryl)
moderateMild CYP2D6 inhibitor; can modestly raise metoprolol levels; may increase dizziness.
Quinidine / Propafenone
moderatePotent CYP2D6 inhibitors; can significantly raise metoprolol concentrations.
Hydralazine
moderateMay inhibit first-pass metabolism of metoprolol, increasing its blood levels.
Toprol XR (metoprolol succinate extended-release) is a cornerstone cardiovascular medication — effective, well-studied, and available as an affordable generic. For patients with high blood pressure, angina, or heart failure, it provides once-daily dosing with consistent 24-hour control. The key safety message that all patients must know: never stop this medication abruptly. Always taper with your doctor's guidance.
While Toprol XR oral tablets are not in an active FDA shortage, stocking gaps at chain pharmacies do occur — particularly for less common doses. If you're having trouble filling your prescription, try an independent pharmacy, use mail-order for 90-day fills, or ask your doctor about a dose-splitting alternative while you locate your usual strength.
If you're struggling to find Toprol XR near you, medfinder calls pharmacies in your area to identify which ones have your medication in stock, and texts you the results — no hold music, no wasted trips to the pharmacy.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini